The novel M4 PAM PET tracer [11C] MK‐6884: a novel biomarker for measuring target engagement of muscarinic M4 positive allosteric modulators (PAMs) as well as cholinergic tone in patients with Alzheimer’s disease

MLA

Wenping Li, et al. “The Novel M4 PAM PET Tracer [11C] MK‐6884: A Novel Biomarker for Measuring Target Engagement of Muscarinic M4 Positive Allosteric Modulators (PAMs) as Well as Cholinergic Tone in Patients with Alzheimer’s Disease.” Alzheimer’s & Dementia, vol. 18, Dec. 2022. EBSCOhost, https://doi.org/10.1002/alz.067249.

APA

Wenping Li, Anthony S Basile, Ling Tong, Koen Van Laere, Joseph C. Masdeu, Eric D Hostetler, Fiona Marshall, & Jason M. Uslaner. (2022). The novel M4 PAM PET tracer [11C] MK‐6884: a novel biomarker for measuring target engagement of muscarinic M4 positive allosteric modulators (PAMs) as well as cholinergic tone in patients with Alzheimer’s disease. Alzheimer’s & Dementia, 18. https://doi.org/10.1002/alz.067249

Chicago

Wenping Li, Anthony S Basile, Ling Tong, Koen Van Laere, Joseph C. Masdeu, Eric D Hostetler, Fiona Marshall, and Jason M. Uslaner. 2022. “The Novel M4 PAM PET Tracer [11C] MK‐6884: A Novel Biomarker for Measuring Target Engagement of Muscarinic M4 Positive Allosteric Modulators (PAMs) as Well as Cholinergic Tone in Patients with Alzheimer’s Disease.” Alzheimer’s & Dementia 18 (December). doi:10.1002/alz.067249.